The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

The CIAC moved Saturday’s Class SS state football championship game between Killingly and Hand from the Coast Guard Academy ...

Sheehan quarterback Jake O’Brien and running back Josh Durant have been in state finals before and have a good chemistry and ...

Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...

Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences community.

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic ...